Veru Inc. (VERU) income statement
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.31+0.17 (+7.94%)
Close on Nov 18, 2026Market cap $39.39MP/E –Yield –
Veru Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -89.7%
Financial strength
- Current ratio
- 4.42
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 387.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.39
- Dividend yield
- –
See a number that looks wrong?